Provided by Tiger Trade Technology Pte. Ltd.

SCYNEXIS Inc

4.46
+0.01000.22%
Post-market: 4.41-0.0500-1.12%19:30 EDT
Volume:68.81K
Turnover:311.57K
Market Cap:44.29M
PE:-3.34
High:4.70
Open:4.49
Low:4.41
Close:4.45
52wk High:9.20
52wk Low:3.53
Shares:9.93M
Float Shares:7.36M
Volume Ratio:1.09
T/O Rate:0.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3352
EPS(LYR):-1.3793
ROE:-18.38%
ROA:-20.82%
PB:0.66
PE(LYR):-3.23

Loading ...

60 Degrees Pharma appoints Eric Francois to board

Reuters
·
May 19

SCYNEXIS Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Scynexis Q1 net loss widens on higher R&D costs

Reuters
·
May 12

SCYNEXIS Q1 EPS $(0.42) Misses $(0.12) Estimate

Benzinga Earnings
·
May 12

Scynexis Reports First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
May 12

Scynexis Q1 Basic EPS USD -0.42

THOMSON REUTERS
·
May 12

Scynexis Q1 Operating Expenses USD 16.939 Million

THOMSON REUTERS
·
May 12

SCYNEXIS Reports First Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
May 12

SCYNEXIS Q1 FY26 net loss widens to $21.3 million; R&D expense more than doubles to $12.4 million

Reuters
·
May 12

SCYNEXIS Inc expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
May 11

SCYNEXIS grants new VP stock options for 125,000 shares at $0.93, plus 20,000 RSUs

Reuters
·
May 07

Scynexis Announces Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 07

Press Release: SCYNEXIS Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Dow Jones
·
May 07

Scynexis files to sell 87M shares of common stock for holders

TIPRANKS
·
May 02

Scynexis Inc - Selling Stockholders Offer 87,000,000 Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
May 02

SCYNEXIS announces special shareholder meeting

Reuters
·
Apr 18

SCYNEXIS CEO David Angulo Gonzalez buys common shares for $0.1 million

Reuters
·
Apr 02

SCYNEXIS buys PXL-770 asset from Poxel for USD 8 million upfront

Reuters
·
Apr 01

SCYNEXIS Enters $40 Million Private Placement, Completes Acquisition of PXL-770 to Treat Kidney Disease

MT Newswires Live
·
Mar 31

Poxel announces sale of PXL770 to Scynexis for up to $196M

TIPRANKS
·
Mar 31